GE HealthCare Technologies Inc. $GEHC Shares Sold by Retirement Planning Group LLC NY

Key Points

• Retirement Planning Group LLC NY reduced its stake in GE HealthCare Technologies by 64.2%, owning now 3,010 shares valued at approximately $223,000 after the sale.
• Institutional investors and hedge funds hold 82.06% of the company's stock, indicating significant institutional interest in GE HealthCare Technologies.
• GE HealthCare Technologies recently declared a quarterly dividend of $0.035 per share, with the payment scheduled for November 14th, reflecting a 0.2% dividend yield.

Retirement Planning Group LLC NY trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 64.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,010 shares of the company's stock after selling 5,401 shares during the quarter. Retirement Planning Group LLC NY's holdings in GE HealthCare Technologies were worth $223,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in GEHC. Hotchkis & Wiley Capital Management LLC raised its stake in GE HealthCare Technologies by 3.2% in the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company's stock valued at $464,226,000 after purchasing an additional 176,572 shares during the last quarter. JPMorgan Chase & Co. raised its stake in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company's stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in GE HealthCare Technologies by 3.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company's stock valued at $398,975,000 after purchasing an additional 157,839 shares during the last quarter. Canada Pension Plan Investment Board raised its stake in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company's stock valued at $251,121,000 after purchasing an additional 409,636 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in GE HealthCare Technologies by 3.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company's stock valued at $247,708,000 after purchasing an additional 109,858 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

GEHC has been the subject of several recent research reports. Wall Street Zen downgraded GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, September 20th. BTIG Research reissued a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research note on Thursday, September 18th. Zacks Research downgraded GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 29th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. Six analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and an average price target of $85.78.

GE HealthCare Technologies Stock Down 4.3%

Shares of GEHC opened at $71.01 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a market capitalization of $32.42 billion, a PE ratio of 14.55, a price-to-earnings-growth ratio of 2.71 and a beta of 1.13. The stock has a fifty day simple moving average of $74.31 and a two-hundred day simple moving average of $72.28. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company's revenue for the quarter was up 3.5% on a year-over-year basis. During the same period last year, the company earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies's dividend payout ratio is currently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.